MedPath

Fertility Preservation in Transgender Persons: A Retrospective Look

Completed
Conditions
Fertility Preservation in Transgender Persons
Registration Number
NCT05120245
Lead Sponsor
University Hospital, Ghent
Brief Summary

Patients in this study will be asked how they feel about the decision to freeze gametes, using a validated questionnaire. In addition, a number of questions with free text fields will be included in the questionnaire to write down any reasons for their satisfaction or regret. In a second part, the intention to use the frozen material will be assessed. We focus on techniques with real perspectives (e.g. cryopreservation of oocytes and sperm cells) and not on techniques that are more experimental for later use (cryopreservation of ovarian and testicular tissue).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Dutch speaking
  • Sperm or oocyte preservation between june 2015 and june 2020. Survey in 2021
Exclusion Criteria
  • Ovarian and testicular tissue cryopreservation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Satisfaction/ regret about the decisionfertility preservation between june 2015 and june 2020 (5 years). Survey in 2021 (up to 7 years after preservation)

Survey on the reasons for satisfaction/ regret regarding the decision to freeze egg cells or sperm cells prior to gender-confirming hormonal or surgical treatment in the context of transition

Intentionfertility preservation between june 2015 and june 2020 (5 years). Survey in 2021 (up to 7 years after preservation)

Examination of the intention to use the frozen egg cells or sperm cells to fulfil a desire to have children

Transgender people's retrospective view of the decisionfertility preservation between june 2015 and june 2020 (5 years). Survey in 2021 (up to 7 years after preservation)

Study of transgender persons' retrospective evaluation of the decision to freeze egg or sperm cells prior to gender-confirming hormonal or surgical treatment in transition

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ghent University hospital

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath